SEOM‑GETTHI clinical guideline for the practical management of molecular platforms (update 2026)
Identification of molecular alterations in cancer and advances in technology have enhanced the use of molecular alterations for the diagnosis and treatment of cancer in routine clinical practice. Multi-determination platforms are now available in most Spanish hospitals. First developed in 2021, the objective of these clinical practice guidelines is to review the usefulness of molecular platforms and establish usage guidelines to direct their incorporation into clinical practice. Here, we provide updated guidelines, which include the most recent advancements in this area.
Authors
- C. Beato Zambrano (ORCID: https://orcid.org/0000-0002-1349-2652)
- Nuria Rodríguez Salas (ORCID: https://orcid.org/0000-0001-7863-6103)
- Ferran Ferragut Lloret
- Rosa María Rodríguez Alonso
- Martín Oré Arce
- María Ángeles Vaz Salgado (ORCID: https://orcid.org/0000-0002-5913-9002)
- Jesús García-Donás Jiménez
- Juan de la Haba-Rodriguez
- Rafael López López
- Ana Cardeña Gutiérrez
Institutions
- Hospital Universitario La Paz (ES)
- Hospital Universitario Nuestra Señora de Candelaria (ES)
- Instituto Maimónides de Investigación Biomédica de Córdoba (ES)
- Centro Oncológico de Galicia (ES)
- Hospital General Universitario de Ciudad Real (ES)
- Hospital Universitario Reina Sofía (ES)
- Complexo Hospitalario Universitario A Coruña (ES)
- Hospital Jerez Puerta del Sur (ES)
- Hospital Marina Baixa (ES)
- Hospital Universitario Ramón y Cajal (ES)
- University of Córdoba (ES)
Publication Details
- Journal
- Clinical & Translational Oncology
- Published
- 2026-07-27
- DOI
- https://doi.org/10.1007/s12094-026-04520-4
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sociedad Española de Oncología Médica